Single-Cell Profiling Reveals Stromal-Immune Remodeling in HNSCC After TPF-Based Neoadjuvant Chemotherapy

Dongliang Wei1,2,3,4,5,6, Yilan Sun1,2,3,4,5,6, Jing Han1,2,3,4,5,6

  • 1Department of Oral and Maxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Head & Neck
|July 24, 2026
PubMed
Summary

Neoadjuvant chemotherapy alters the head and neck cancer microenvironment. Post-treatment regression areas and residual tumors show distinct fibroblast populations, impacting tumor heterogeneity.

Related Concept Videos